KR20170072352A - 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물 - Google Patents

조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물 Download PDF

Info

Publication number
KR20170072352A
KR20170072352A KR1020177015741A KR20177015741A KR20170072352A KR 20170072352 A KR20170072352 A KR 20170072352A KR 1020177015741 A KR1020177015741 A KR 1020177015741A KR 20177015741 A KR20177015741 A KR 20177015741A KR 20170072352 A KR20170072352 A KR 20170072352A
Authority
KR
South Korea
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
tissue
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020177015741A
Other languages
English (en)
Korean (ko)
Inventor
라인 객넌
피에르 라우린
Original Assignee
프로메틱 파마 에스엠티 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로메틱 파마 에스엠티 리미티드 filed Critical 프로메틱 파마 에스엠티 리미티드
Publication of KR20170072352A publication Critical patent/KR20170072352A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32—Phenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020177015741A 2014-11-12 2015-11-12 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물 Ceased KR20170072352A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462078704P 2014-11-12 2014-11-12
US62/078,704 2014-11-12
PCT/CA2015/000572 WO2016074068A1 (en) 2014-11-12 2015-11-12 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Publications (1)

Publication Number Publication Date
KR20170072352A true KR20170072352A (ko) 2017-06-26

Family

ID=55953490

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177015741A Ceased KR20170072352A (ko) 2014-11-12 2015-11-12 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물

Country Status (19)

Country Link
US (3) US10391073B2 (enExample)
EP (1) EP3217968A4 (enExample)
JP (1) JP6720169B2 (enExample)
KR (1) KR20170072352A (enExample)
CN (1) CN107106526B (enExample)
AR (1) AR102634A1 (enExample)
AU (2) AU2015345943B2 (enExample)
BR (1) BR112017009899A2 (enExample)
CA (1) CA2967499C (enExample)
IL (1) IL252221B (enExample)
MX (1) MX381687B (enExample)
MY (1) MY187515A (enExample)
PH (1) PH12017500856A1 (enExample)
RU (1) RU2728782C2 (enExample)
SG (1) SG11201703741TA (enExample)
TW (1) TWI723967B (enExample)
UY (1) UY36399A (enExample)
WO (1) WO2016074068A1 (enExample)
ZA (1) ZA201703579B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
KR20170072352A (ko) * 2014-11-12 2017-06-26 프로메틱 파마 에스엠티 리미티드 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2289417C1 (ru) * 2005-04-15 2006-12-20 Равиль Шамилевич Мирхайдаров Способ биологического омоложения кожи
EP1953222A1 (en) * 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
KR20120090011A (ko) * 2009-05-04 2012-08-16 프로메틱 바이오사이언시즈 인코포레이티드 3-펜틸페닐아세트산의 염 및 이의 약학적 용도
WO2010127440A1 (en) 2009-05-04 2010-11-11 Prometic Biosciences Inc. Substituted aromatic compounds and pharmaceutical uses thereof
ES2351005B1 (es) * 2009-07-10 2011-11-18 Consejo Superior De Investigaciones Científicas (Csic) Uso de anhidrasa carbónica ii para la elaboración de un medicamento.
US9475750B2 (en) 2010-10-27 2016-10-25 Prometic Biosciences Inc. Phenylketone carboxylate compounds and pharmaceutical uses thereof
DK3443957T3 (da) 2010-10-27 2020-12-21 Liminal Biosciences Ltd Forbindelser og sammensætninger til behandling af cancer
US20130225683A1 (en) * 2010-10-27 2013-08-29 Prometic Biosciences Inc. Compounds and Pharmaceutical Compositions for Uses in Diabetes
JP5388233B2 (ja) * 2011-01-19 2014-01-15 富士ソフト株式会社 再生軟骨の軟骨特性を評価する方法
US20140170125A1 (en) * 2011-08-10 2014-06-19 Digna Biotech, S.L. Use of cardiotrophin-1 for the treatment of kidney diseases
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
TWI689490B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
CA2963276A1 (en) 2014-10-10 2016-04-14 Prometic Biosciences Inc. Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
PL3203999T3 (pl) 2014-10-10 2020-07-27 Liminal Biosciences Limited Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia osteoporozy
KR20170072352A (ko) * 2014-11-12 2017-06-26 프로메틱 파마 에스엠티 리미티드 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물

Also Published As

Publication number Publication date
IL252221A0 (en) 2017-07-31
JP6720169B2 (ja) 2020-07-08
MY187515A (en) 2021-09-24
CA2967499C (en) 2023-01-17
PH12017500856A1 (en) 2017-11-06
AR102634A1 (es) 2017-03-15
MX381687B (es) 2025-03-13
AU2015345943A1 (en) 2017-06-01
US20210085626A1 (en) 2021-03-25
CN107106526B (zh) 2021-05-28
EP3217968A4 (en) 2018-06-20
EP3217968A1 (en) 2017-09-20
JP2017533928A (ja) 2017-11-16
AU2020204112B2 (en) 2021-10-21
TW201618764A (zh) 2016-06-01
IL252221B (en) 2022-04-01
US20200078324A1 (en) 2020-03-12
UY36399A (es) 2016-06-30
BR112017009899A2 (pt) 2018-01-16
RU2728782C2 (ru) 2020-07-31
SG11201703741TA (en) 2017-06-29
CN107106526A (zh) 2017-08-29
US10869849B2 (en) 2020-12-22
MX2017006281A (es) 2017-08-14
RU2017120401A (ru) 2018-12-13
TWI723967B (zh) 2021-04-11
AU2015345943B2 (en) 2020-03-19
ZA201703579B (en) 2018-08-29
AU2020204112A1 (en) 2020-07-09
CA2967499A1 (en) 2016-05-19
US10391073B2 (en) 2019-08-27
WO2016074068A1 (en) 2016-05-19
RU2017120401A3 (enExample) 2019-06-06
US20170312237A1 (en) 2017-11-02

Similar Documents

Publication Publication Date Title
CN101605754B (zh) 具有快速皮肤穿透速度的带正电荷的水溶性的维生素a酸类和类维生素a酸化合物的前药
KR20110025734A (ko) 중추신경계 질환 및 질병 치료에 유효한 신규 화합물
EP2623495A1 (en) Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
CN101885684A (zh) 带有一氧化氮供体的芳香酸前体药物及其制备方法和其应用
JP4268872B2 (ja) ３，４，５−トリメトキシフェニル系のエステル化合物及びこれを含有する美白化粧料組成物
US20210085626A1 (en) Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
KR101505446B1 (ko) 5-아미노레불린산의 제조방법 및 그 용도
JP2002541205A (ja) 皮膚および粘膜に関する生理学的並びに病理学的事象を制御するためのテトラヒドロクルクミノイドの使用方法およびそのテトラヒドロクルクミノイドの製造方法
CN110121491B (zh) 3,4,5-三甲氧基肉桂酸酯衍生物、其制备方法以及含有该衍生物的皮肤美白组合物
KR101248025B1 (ko) 티오세미카바존 유도체를 함유한 미백용 조성물
KR101461625B1 (ko) 16-히드록시헥사데카노익 피토스핑고신을 유효성분으로 포함하는 피부장벽 손상의 개선 또는 치료, 또는 피부장벽 기능의 개선 또는 강화용 조성물
CN110621654B (zh) Trpv1调节剂化合物
JP4145609B2 (ja) メントール誘導体及びその製造方法
JP5328254B2 (ja) セラミド産生促進剤
JP3805901B2 (ja) 芳香族抗真菌剤
KR100245797B1 (ko) 세라미드 유사 화합물 및 이의 제조방법
EP2556819A1 (en) External skin preparation
CN117209539A (zh) 一种多环化合物及其制备方法与用途
HK40054569A (en) Prodrugs of retinoids and retinoid-like compounds
JP2010111622A (ja) 毛穴収縮剤
HK1137413B (en) Positively charged water-soluble prodrugs of retinoids and retinoid-like compounds with very high skin penetration rates
US20160362402A1 (en) Novel compounds having anti-allodynic and antihyperalgesic activity
WO2004032914A2 (en) Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170609

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201110

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230220

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20230425

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20230220

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I